Functionally, EPHX1-derived AA promotes ferroptosis and suppresses tumor proliferation, whereas TRIM21-mediated EPHX1 degradation sustains AA depletion, thereby enhancing pancreatic cancer growth and conferring gemcitabine resistance (Fan et al., 2025). The gene discussed is EPHX1; the disease is familial pancreatic carcinoma.